Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 15 Jun 2026 for Biocryst Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleJon P. Stonehouse
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jon P. Stonehouse: trading record in brief
Jon P. Stonehouse is a declared insider at 3 companies (chief executive); the most frequent names are Biocryst Pharmaceuticals Inc, Bellicum Pharmaceuticals, Inc and Metsera, Inc. We count 33 filings; the first trade dates from 1 January 2016 and the latest from 11 June 2026.
In open-market terms, that means 1 purchase worth €154k on one side and 1 sale worth €144k on the other. Purchases outweigh sales by €10k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 13 share grants and 9 option exercises.
The record was last updated on 15 June 2026 with a share grant in Biocryst Pharmaceuticals Inc. The clock since the last published purchase (15 May 2024) now reads 886 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jon P. Stonehouse
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
15,294 sharesCommon StockSEC:0000882796-26-000039:0
631 shares@ US$8.910.0002% mcap0.2% of flowCommon StockSEC:0000882796-26-000031:0
421 shares@ US$8.750.1% of flowCommon StockSEC:0000882796-26-000011:0
61,793 shares@ US$7.4113.1% of flowCommon StockSEC:0000882796-25-000045:0
20,000 shares0Common StockSEC:0001171843-25-008039:0
27,368 shares@ US$7.577.4% of flowCommon StockSEC:0000882796-25-000031:0
2,688 sharesCommon StockSEC:0001193125-25-280798:0
14,010 shares@ US$7.393.3% of flowCommon StockSEC:0001127602-24-029948:1
362,100 shares0Common StockSEC:0001127602-24-029948:0
20,000 shares0Common StockSEC:0001127602-24-029948:2
10,000 shares0Common StockSEC:0001127602-24-029948:3
10,000 shares0Common StockSEC:0001127602-24-029948:4
27,525 shares@ US$7.536.6% of flowCommon StockSEC:0001127602-24-029592:0
30,000 shares@ US$5.555.2% of flowCommon StockSEC:0001127602-24-015365:0
Canonical exit: 11 Aug 2024 (T+90)
20,000 shares0Common StockSEC:0001127602-24-000832:0
14,089 shares@ US$6.052.6% of flowCommon StockSEC:0001127602-23-030187:0
127,500 shares0Common StockSEC:0001127602-23-029835:0
25,000 shares0Common StockSEC:0001171843-23-003946:0
31,055 shares@ US$3.223.1% of flowCommon StockSEC:0001127602-23-011193:0
10,000 shares0Common StockSEC:0001127602-23-003172:0
121,452 shares0Common StockSEC:0001628280-23-000419:0
60,580 shares0Common StockSEC:0001628280-23-000354:0
127,500 shares0Common StockSEC:0001127602-22-028080:0
14,100 shares@ US$10.904.8% of flowCommon StockSEC:0001127602-22-027894:0
214,917 shares@ US$1.429.8% of flowCommon StockSEC:0001127602-22-026832:0
25 of 33 declarations
